A 68-year-old man with undifferentiated carcinoma occurring in the cardioesophageal junction accompanied by hypercalcemia is reported. The serum level of parathyroid hormone-related protein (PTHrP) was remarkably elevated. Serum calcium and PTHrP levels decreased following chemotherapy, but this amelioration was temporary. He died of hypercalcemia. Onautopsy, a significant amount of immunoreactive PTHrPwas detected in the tumor tissue extract, and the tumor cells were stained strongly positive for PTHrPby immunohistochemistry. This is the first case of undifferentiated carcinoma in the gastrointestinal tract which demonstrated hypercalcemia due to PTHrP produced by the malignant tumor. (Internal Medicine 34: 695-699, 1995) 
Introduction
Humoral hypercalcemia of malignancy (HHM)is a wellknownmetabolic complication of malignant tumors. It has been shown that parathyroid hormone-related protein (PTHrP) is a major pathogenetic factor for HHM ( 1 ) . Wereport here a patient with undifferentiated carcinoma in the cardioesophageal junction, whopresented with hypercalcemia due to PTHrPproduced by the tumor.
Case Report
A 68-year-old Japanese man experienced several episodes of hematemesis on November22, 1992. He was immediately transferred to our hospital by ambulance, and admitted for further examination and treatment. On admission, his height was 160 cm, and he weighed 65 kg. Bloodpressure was 140/92 mmHg, and heart rate was 90 beats/min. He had anemia but no jaundice. No superficial lymph nodes were palpable. The laboratory data on admission were as follows: hemoglobin: 9.8 g/dl, white blood cell count: 6,900/mm3, C-reactive protein: 3. 1 mg/ dl, glutamic-oxaloacetic transaminase: 5 1 IU/1, glutamic pyruvic transaminase: 49 IU/1, lactate dehydrogenase: 432 U, alkaline phosphatase: 675 mU/ml (increased liver isoenzyme), sodium: 148 mEq/1, potassium: 4.3 mEq/1, calcium (Ca): 12.5 mg/dl and phosphorus: 1.1 mg/dl. Tumor markers examined, including alpha-fetoprotein, carcinoembryonic antigen , carbohydrate antigen 19-9, pancreatic oncofetal antigen and squamous cell carcinoma-related antigen, were all within normal limits , except for neuron-specific enolase which was elevated to 12.6 ng/ml. Endocrinological studies such as adrenocorticotropic hormone (ACTH), antidiuretic hormone (ADH) , growth hormoneand cortisol were normal, whereas the intact-parathyroid hormone (PTH) was decreased (<5 pg/ml). An endoscopic examination revealed a protruding lesion with an easily-bleeding ulcer in the cardioesophageal junction. The lesion was pathologically diagnosed as undifferentiated carcinoma by biopsy specimens. The lungs were normal on plain X-ray, computed tomography (CT) and bronchofiberscopy. Abdominal CT revealed multiple low density areas on the whole liver lobe, a finding compatible with hepatic metastases. A bone scintigram with technetium 99mdemonstrated no increased uptake of radioactivity at any site. After admission, hypercalcemia was not improvedin spite of various medical treatments (intravenous administration of diuretics, calcitonin and prednisolone with sufficient amounts of fluid). The patient was given a course of chemotherapy with cisplatin (130 mg, intravenously, on day 1), epirubicin (50 mg, intravenously, on day 1) and etoposide (100 mg, intravenously, from day 1 to day 5). This chemotherapy successfully decreased his serum Ca con-centration to the normal range, and the primary and metastatic lesions were reduced in size. But this improvement wastemporary, and hypercalcemia developed again. Although the same regimen of chemotherapy was given 2 more times, the effectiveness of the therapy was gradually decreased. Because hypercalcemia became unresponsive to the chemotherapy regimen, the patient was treated with a different protocol of chemotherapy with cyclophosphamide (1,000 mg, intravenously), epirubicin (40 mg, intravenously) and vincristine (1.4 mg, intravenously) , which was ineffective. Hypercalcemia deteriorated progressively, and the patient died on April 3, 1993.
Pathologic study At autopsy, the lesion (5x2 cm) which extended from the abdominal portion of the esophagus to the lesser curvature of the cardia, and was located mainly around the cardioesophageal junction, had a gross appearance of poorly-defined protrusion covered by normal-appearing mucosawith central ulceration ( Fig. 1) . The tumor existed mainly in the submucosa layer expanding to the muscularis. The tumor was composed of oval or round cells whichwere arranged in a solid, nest or trabecular pattern (Fig. 2 ). Most tumor cells had basophilic, moderately scanty cytoplasm with small, round or oval hyperchromatic nuclei. In some areas, the tumor cells had moderately abundant cytoplasm with larger nuclei. Alucian-blue-PAS staining was negative for the neoplastic cells. The tumor did not show any findings of squamouscell carcinoma or adenocarcinoma differentiation as characterized by keratinization or glandular formation.
The liver, weighing 2,200 g, had white-gray multiple nodules with shallow central depression, which were consistent with metastatic tumors. Metastatic lesions also were found in the lungs, left adrenal gland, perigastric lymph nodes and peripancreatic lymph nodes. Histologically, metastatic lesions were composedof neoplastic cells that were similar to those of the primary tumor.
Electron microscopy
The specimens from the primary lesion were fixed in 1% osmiumtetroxide for electron microscopic observations. Tumor cells with oval nuclei which appeared partly indented were closely apposed. The nuclei were clear and had abundant euchromatin with well-developed nucleoli showing elongated and twisted strands (Fig. 3) . The relatively scanty cytoplasm contained well-developed ribosomes and polysomes. Electrondense bodies also were found in the cytoplasm. The cell membranewas slightly interdigitating, and the desmosomewas observed occasionally. However, extensive search failed to reveal any components of squamous cell differentiation such as PTHrP 
Immunohistochemistry
Immunohistochemistry was carried out by the method described in a previous report (3) . Tissues were fixed in 5% paraformaldehyde solution buffered with phosphate-buffered saline (50 mM,pH 7.4) and embedded in paraffin. Microtome sections (3 |im) were stained by the avidin-biotin peroxidase Figure 5 . Immunohistochemical findings of the primary lesion (x200). Tumorcells were stained strongly positive for immunoreactive PTHrP. tonofilament and tonofilament-desmosome complex, and also those of adenocarcinoma such as mucigen, junctional complex and intracytoplasmic lumen. On the basis of these morpholoical findings, the tumor was diagnosed as undifferentiated carcinoma.
Serum PTHrP Serum PTHrPlevels were measured by radioimmunoassay (RIA) using the antisera against human PTHrP 109-141 (CPTHrP) and PTHrP 1-34 (N-PTHrP) as described previously (2, 3) . Figure 4 shows changes in serum C-PTHrP and Ca levels in response to medical treatments. All serum Ca values were corrected by the respective serum albumin levels. The serum CPTHrPlevel on admission was remarkably elevated to 814 pmol/1 (normal value: 3 1.4+7.4 pmol/1 (2)). C-PTHrP and Ca levels were dramatically decreased following the initiation of chemotherapy, but they were elevated during the interruption of each chemotherapy course. The changes in C-PTHrP level were parallel to those of serum Ca level. The highest Ca and CPTHrP concentrations were 18.9 mg/dl and 1,312.7 pmol/1, respectively, which were observed on March 31, 1993. NPTHrP was also elevated (56 pg/ml on March 30, 1993, normal range <20 pg/ml (4)).
PTHrP in tumor tissue
The tumor tissue in the liver obtained by autopsy was rapidly frozen on dry ice and stored at -70°C. The frozen tissue was extracted by the method reported previously (5) , and the tissue content of PTHrPwas determined by N-PTHrPRIA (3). The complex (ABC) method with a Vectastain ABCkit (Vector Laboratories, Burlingame, CA). The N-PTHrPantiserum used for RIA was applied. Tumor cells in both primary and metastatic lesions were stained strongly positive for PTHrP (Fig. 5) .
Discussion
Hypercalcemia is a well-known metabolic complication of malignant tumors, and it is often life-threatening unless adequately treated. About 75%of cases with malignancy-associated hypercalcemia were reported to be HHM (6) . In the present case, the serum C-PTHrP level was highly increased on admission, and decreased in response to chemotherapy, which was concomitantly accompanied by the normalization of serum Ca level and the reduction of tumor size. Serumand tissue NPTHrPcontents were also elevated, and the tumor cell was immunohistochemically positive for N-PTHrP. These findings strongly suggest that the tumor produced PTHrP, which in turn caused hypercalcemia.
HHM is a commoncomplication of malignant cancers, particularly of squamous cell carcinomas (6) and hematopoietic malignant diseases such as adult T cell leukemia. The incidence of HHM in esophageal cancers is reported to range from 13-28% (7-9), and Tachimori et al demonstrated that esophageal squamous cell carcinomas could produce PTHrP (10) . On the other hand, HHMis rare in gastric carcinomas because the most common histologic type of this malignant tumor is adenocarcinoma. Although Yamaura-Idei et al recently reported that it is not completely rare for gastric carcinomas to stain immunohistochemically positive for PTHrP (1 1); there is no reported case of gastric carcinoma showing that circulating PTHrP released from tumor cells induces hypercalcemia. Undifferentiated carcinomas generally undergo an aggressive clinical course. Since undifferentiated carcinoma cells are frequently already disseminated at the time of diagnosis, it is difficult to determine the primary lesion of carcinomas. In the present case, we endoscopically found at the cardioesophageal junction a protruded tumor with central ulceration, which was covered by the normal mucosa. Since these gross appearances are commonfor esophageal undifferentiated carcinomas in the early stage (12), the cardioesophageal lesion in the present case was thought to be the primary tumor. Although the primary tumor was relatively small, the patient had already suffered massivehepatic metastaseson admission.Therewasa report of massive hepatic metastases occurring in early gastric undifferentiated carcinomawithin a short period of time after a curative operation (13). Because of this biological behavior, there are few cases in which surgical treatment is performed as the primary therapy for esophageal or gastric undifferentiated carcinomas.
For In summary, we described a patient with PTHrP-producing undifferentiated carcinoma occurring in the cardioesophageal junction, which was definitely proven by RIA and immunohistochemistry. To our knowledge, this is the first case ofPTHrPproducing undifferentiated carcinoma in the gastrointestinal tract.
